Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Discovery of isoquinoline sulfonamides as allosteric gyrase inhibitors with activity against fluoroquinolone-resistant bacteria

    Bacteria have evolved resistance to nearly all known antibacterials, emphasizing the need to identify antibiotics that operate via novel mechanisms. Here we report a class of allosteric inhibitors of DNA gyras...

    Alexander T. Bakker, Ioli Kotsogianni, Mariana Avalos, Jeroen M. Punt in Nature Chemistry (2024)

  2. Article

    Open Access

    Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease

    SARS-CoV2 infection results in a range of disease severities, but the underlying differential pathogenesis is still not completely understood. At presentation it remains difficult to estimate and predict sever...

    Krista E. van Meijgaarden, Suzanne van Veen, Roula Tsonaka in Scientific Reports (2024)

  3. Article

    Open Access

    Age and sex influence antibody profiles associated with tuberculosis progression

    Antibody features vary with tuberculosis (TB) disease state. Whether clinical variables, such as age or sex, influence associations between Mycobacterium tuberculosis-specific antibody responses and disease state...

    Leela R. L. Davies, Chuangqi Wang, Pia Steigler, Kathryn A. Bowman in Nature Microbiology (2024)

  4. Article

    Open Access

    BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination

    Bacillus Calmette-Guèrin - vaccination induces not only protection in infants and young children against severe forms of tuberculosis, but also against non-tuberculosis related all-cause mortality. To delineat...

    Krista E. van Meijgaarden, Wenchao Li, Simone J. C. F. M. Moorlag in Nature Communications (2024)

  5. Article

    Open Access

    Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

    Tuberculosis (TB) is a prevalent disease causing an estimated 1.6 million deaths and 10.6 million new cases annually. Discriminating TB disease from differential diagnoses can be complex, particularly in the f...

    Paula Niewold, Douwe J. Dijkstra, Yi Cai, Delia Goletti in Scientific Reports (2023)

  6. Article

    Open Access

    Ebola virus–like particles reprogram cellular metabolism

    Ebola virus can trigger a release of pro-inflammatory cytokines with subsequent vascular leakage and impairment of clotting finally leading to multiorgan failure and shock after entering and infecting patients...

    Huaqi Tang, Yasmine Abouleila, Anno Saris in Journal of Molecular Medicine (2023)

  7. Article

    Open Access

    Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice

    Viral-vectored vaccines are highly amenable for respiratory mucosal delivery as a means of inducing much-needed mucosal immunity at the point of pathogen entry. Unfortunately, current monovalent viral-vectored...

    Sam Afkhami, Michael R. D’Agostino, Maryam Vaseghi-Shanjani in npj Vaccines (2023)

  8. Article

    Open Access

    Leptin mutation and mycobacterial infection lead non-synergistically to a similar metabolic syndrome

    The leptin signaling pathway plays an important role as a key regulator of glucose homeostasis, metabolism control and systemic inflammatory responses. However, the metabolic effects of leptin on infectious di...

    Yi Ding, Mariëlle C. Haks, Susan J. F. van den Eeden, Tom H. M. Ottenhoff in Metabolomics (2022)

  9. No Access

    Protocol

    Discovery of HLA-E-Presented Epitopes: MHC-E/Peptide Binding and T-Cell Recognition

    Understanding the interactions involved during the immunological synapse between peptide, HLA-E molecules, and TCR is crucial to effectively target protective HLA-E-restricted T-cell responses in humans. Here ...

    Paula Ruibal, Kees L. M. C. Franken in T-Cell Repertoire Characterization (2022)

  10. Article

    Open Access

    In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination

    Novel tuberculosis (TB)-vaccines preferably should (i) boost host immune responses induced by previous BCG vaccination and (ii) be directed against Mycobacterium tuberculosis (Mtb) proteins expressed throughout t...

    Mariateresa Coppola, Fabienne Jurion, Susan J. F. van den Eeden in npj Vaccines (2021)

  11. No Access

    Chapter

    Conventional and Unconventional Lymphocytes in Immunity Against Mycobacterium tuberculosis

    Tuberculosis is one of the leading infectious diseases threatening human and animal global health. Human tuberculosis ranks among the top 10 causes of overall mortality world-wide. Conventional and unconventio...

    Paula Ruibal, Tom H. M. Ottenhoff in Advances in Host-Directed Therapies Agains… (2021)

  12. Article

    Open Access

    Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    David Pejoski, Casimir de Rham, Paola Martinez-Murillo, Francesco Santoro in npj Vaccines (2020)

  13. Article

    Open Access

    Tuberculosis causes highly conserved metabolic changes in human patients, mycobacteria-infected mice and zebrafish larvae

    Tuberculosis is a highly infectious and potentially fatal disease accompanied by wasting symptoms, which cause severe metabolic changes in infected people. In this study we have compared the effect of mycobacteri...

    Yi Ding, Robert-Jan Raterink, Rubén Marín-Juez, Wouter J. Veneman in Scientific Reports (2020)

  14. Article

    Open Access

    Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes

    Tuberculosis (TB) is a global health concern. Treatment is prolonged, and patients on anti-TB therapy (ATT) often experience treatment failure for various reasons. There is an urgent need to identify signature...

    Dhanasekaran Sivakumaran, Synne Jenum, Mario Vaz, Sumithra Selvam in Communications Biology (2020)

  15. Article

    Open Access

    Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017

    Screening for latent tuberculosis infection (LTBI) is indicated before immunosuppressive therapies but is complicated by lack of a gold standard and limited by, e.g., immunosuppression. This study aimed to inv...

    Jonathan W. Uzorka, Dinah L. Duinkerk in European Journal of Clinical Microbiology … (2020)

  16. Article

    Open Access

    Analyzing the impact of Mycobacterium tuberculosis infection on primary human macrophages by combined exploratory and targeted metabolomics

    The pathogenic success of Mycobacterium tuberculosis (Mtb) is tightly linked to its ability to recalibrate host metabolic processes in infected host macrophages. Since changes in cellular metabolic intermediates ...

    Frank Vrieling, Sarantos Kostidis, Herman P. Spaink, Mariëlle C. Haks in Scientific Reports (2020)

  17. Article

    Open Access

    Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination

    The rVSV-ZEBOV Ebolavirus vaccine confers protection within days after immunization, suggesting the contribution of innate immune responses. We report modulation of rVSV-ZEBOV vaccinee blood CD56+ NK cell numbers...

    David Pejoski, Casimir de Rham, Paola Martinez-Murillo, Francesco Santoro in npj Vaccines (2020)

  18. Article

    Open Access

    Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis

    Tuberculosis (TB) causes 1.6 million deaths annually. Early differential diagnosis of active TB infection is essential in optimizing treatment and reducing TB mortality, but is hampered by a lack of accurate a...

    Karin Dijkman, Rosalie Lubbers, Nicole V. Borggreven in Scientific Reports (2020)

  19. Article

    Open Access

    Mycobacterium tuberculosis clinical isolates of the Bei**g and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv

    Substantial differences exist in virulence among Mycobacterium tuberculosis strains in preclinical TB models. In this study we show how virulence affects host responses in mice during the first four weeks of infe...

    Bas C. Mourik, Jurriaan E. M. de Steenwinkel, Gerjo J. de Knegt in Scientific Reports (2019)

  20. Article

    Open Access

    Plasma metabolomics in tuberculosis patients with and without concurrent type 2 diabetes at diagnosis and during antibiotic treatment

    Tuberculosis (TB) and type 2 diabetes mellitus (DM), a major TB risk factor, are both accompanied by marked alterations in metabolic processes. Dissecting the specific metabolic changes induced by disease thro...

    Frank Vrieling, Bachti Alisjahbana, Edhyana Sahiratmadja in Scientific Reports (2019)

previous disabled Page of 3